Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Taylor & Francis Group 2019-06-01
Cyfres:CNS Oncology
Pynciau:
bevacizumab
glioblastoma
glioma
long term
progression
recurrence
Mynediad Ar-lein:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Rhyngrwyd

https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Eitemau Tebyg